Cryo-Save Group NV on track to launch Cryo-Lip® in the US
(Thomson Reuters ONE) -
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading
international family stem cell bank, announces that it has incorporated a wholly
owned subsidiary in Delaware, USA. The subsidiary is called Cryo-Save USA, Inc.
and will commercialize and further develop the Cryo-Lip(®) service in North
America. Cryo-Lip(®) allows adults to store stem cells from fat tissue which is
extracted whilst undergoing other surgical procedures.
Preparations towards a full launch of this service in the US are on schedule and
Cryo-Save expects to store its first commercial US samples in Q3 2011.
Cryo-Save USA has already entered into an agreement with General BioTechnology
LLC ("GBT") in Indianapolis. GBT is a FDA and AABB (American Association of
Blood Banks) accredited stem cell bank and will be the strategic partner
responsible for processing and the long-term cryogenic storage of stem cells
from fat tissue.
In order to maintain Cryo-Save's reputation for adhering to the highest
scientific and quality standards, a validation study for Cryo-Lip(®) has been
initiated in the US. Adipose (fat) tissue samples are collected from clinics and
the quality and quantity of adipose-derived stem cells are analyzed following
processing and cryopreservation.
Arnoud van Tulder, Chief Executive of Cryo-Save commented:
"We are excited about the progress made so far in the US and the opportunity for
us to gain a leading position in adult stem cell storage in the US as well as in
Europe.
"Our partnership with GBT will ensure that our work in the US meets Cryo-Save's
renowned high standards and our focus now will be on creating a strong
commercial network".
Enquiries:
Cryo-Save Group + 31 (0) 575 548 998
Arnoud van Tulder, Chief Executive Officer
SPJ Financiële Communicatie (The Netherlands) +31 (0)20 647 8181
Kees Jongsma/Leon Melens
Daniel Stewart & Company plc (UK) + 44 (0) 20 7776 6550
Sean Lunn
College Hill (UK) + 44 (0) 20 7457 2020
Rozi Morris/ Adrian Duffield
Free footage is available on www.videobankonline.com
About Cryo-Save (www.cryo-save.com/group)
Cryo-Save, the leading international family stem cell bank, already stores
175,000 samples from cord blood and umbilical cord tissue for newborns and
adipose tissue for adults. These stem cells can mean the difference between life
and death in the case of future threats to the health of the donors. There are
already several diseases that can be cured by the use of stem cells, and the
number of treatments will only increase. Driven by its international business
strategy, Cryo-Save is now represented in 40 countries on three continents, with
ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India
and France (validation in progress).
Click here for press release in PDF:
http://hugin.info/143308/R/1518174/454707.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE
[HUG#1518174]
Unternehmensinformation / Kurzprofil:
Datum: 25.05.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 54956
Anzahl Zeichen: 3999
contact information:
Town:
Zutphen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 280 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cryo-Save Group NV on track to launch Cryo-Lip® in the US"
steht unter der journalistisch-redaktionellen Verantwortung von
Cryo-Save Group N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
